7749.T JPX
Medikit Co.,Ltd.
1W: -1.1%
1M: -3.7%
3M: +0.1%
YTD: -8.4%
1Y: +10.5%
3Y: +20.0%
5Y: +1.9%
¥2,772.00 ($17.56)
+5.00 (+0.18%)
Weekly Expected Move ±2.0%
¥2660
¥2716
¥2772
¥2828
¥2884
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$52.5B
+2.9% ▲
5Y CAGR: +1.4%
Total Liabilities
$7.3B
+6.5% ▲
5Y CAGR: +10.2%
Shareholders Equity
$45.2B
+2.3% ▲
5Y CAGR: +1.4%
Cash & Investments
$23.1B
-2.3% ▼
5Y CAGR: +72.7%
Total Debt
$0
+0.0% ▲
Net Debt
-$23.1B
+2.3% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $27.5B | $28.1B | $27.6B | $23.6B | $23.1B |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $27.5B | $28.1B | $27.6B | $23.6B | $23.1B |
| Net Receivables | $4.9B | $5.0B | $5.7B | $5.3B | $5.1B |
| Inventory | $3.7B | $3.6B | $3.3B | $3.9B | $4.6B |
| Other Current Assets | $1.6B | $1.8B | $1.6B | $1.7B | $558M |
| Total Current Assets | $37.6B | $38.5B | $38.2B | $34.5B | $33.2B |
| Property, Plant & Equip. | $10.1B | $10.8B | $10.4B | $11.5B | $14.4B |
| Goodwill & Intangibles | $246M | $127M | $3.1B | $3.5B | $3.3B |
| Long-Term Investments | $1.0B | $993M | $947M | $962M | $779M |
| Other Non-Current Assets | $133M | $143M | $129M | $286M | $458M |
| Total Non-Current Assets | $12.3B | $12.5B | $15.0B | $16.5B | $19.2B |
| Total Assets | $49.9B | $51.1B | $53.2B | $51.0B | $52.5B |
| — Liabilities — | |||||
| Accounts Payable | $2.3B | $2.6B | $2.5B | $3.2B | $3.5B |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $153M | $0 |
| Other Current Liabilities | $1.4B | $837M | $949M | $1.1B | $1.4B |
| Total Current Liabilities | $4.2B | $4.4B | $4.7B | $5.7B | $6.2B |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Liab. | $2.1B | $871M | $890M | $816M | $815M |
| Total Non-Current Liabilities | $2.1B | $871M | $1.2B | $1.2B | $1.2B |
| Total Liabilities | $6.3B | $5.3B | $5.9B | $6.9B | $7.3B |
| — Equity — | |||||
| Common Stock | $1.2B | $1.2B | $1.2B | $1.2B | $1.2B |
| Retained Earnings | $35.0B | $37.2B | $38.5B | $39.8B | $37.3B |
| Accumulated OCI | $194M | $243M | $390M | $675M | $740M |
| Total Stockholders Equity | $43.6B | $45.8B | $47.3B | $44.1B | $45.2B |
| Total Liabilities & Equity | $49.9B | $51.1B | $53.2B | $51.0B | $52.5B |
| — Key Metrics — | |||||
| Total Debt | $0 | $0 | $0 | $0 | $0 |
| Net Debt | -$27.5B | -$28.1B | -$27.6B | -$23.6B | -$23.1B |
| Total Investments | $1.0B | $993M | $947M | $962M | $779M |